These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9130309)

  • 21. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.
    Weiner I; Feldon J
    Pharmacol Biochem Behav; 1992 Aug; 42(4):625-31. PubMed ID: 1513845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine.
    Weiner I; Schiller D; Gaisler-Salomon I; Green A; Joel D
    Behav Pharmacol; 2003 May; 14(3):215-22. PubMed ID: 12799523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.
    Warburton EC; Joseph MH; Feldon J; Weiner I; Gray JA
    Psychopharmacology (Berl); 1994 May; 114(4):657-64. PubMed ID: 7855229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antipsychotic drugs on operant responding after acute and repeated administration.
    Varvel SA; Vann RE; Wise LE; Philibin SD; Porter JH
    Psychopharmacology (Berl); 2002 Mar; 160(2):182-91. PubMed ID: 11875636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of apomorphine and clozapine on conditioned freezing and latent inhibition.
    Masson S; Avanzi V; Troncoso AC; Brandão ML
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Sep; 27(6):935-43. PubMed ID: 14499310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early handling and latent inhibition in the conditioned suppression paradigm.
    Weiner I; Feldon J; Ziv-Harris D
    Dev Psychobiol; 1987 Mar; 20(2):233-40. PubMed ID: 3582782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats.
    Feldon J; Weiner I
    Pharmacol Biochem Behav; 1989 Jan; 32(1):123-7. PubMed ID: 2734324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.
    Dunn LA; Atwater GE; Kilts CD
    Psychopharmacology (Berl); 1993; 112(2-3):315-23. PubMed ID: 7871036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facilitation of latent inhibition by the atypical antipsychotic risperidone.
    Alves CR; Silva MT
    Pharmacol Biochem Behav; 2001 Mar; 68(3):503-6. PubMed ID: 11325405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the atypical antipsychotic remoxipride on alcohol self-administration.
    Files FJ; Denning CE; Samson HH
    Pharmacol Biochem Behav; 1998 Feb; 59(2):281-5. PubMed ID: 9476971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Restoration of latent inhibition by olanzapine but not haloperidol in entorhinal cortex-lesioned rats.
    Coutureau E; Gosselin O; Di Scala G
    Psychopharmacology (Berl); 2000 Jun; 150(2):226-32. PubMed ID: 10907677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist.
    Nadal R
    CNS Drug Rev; 2001; 7(3):265-82. PubMed ID: 11607043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of the atypical antipsychotics clozapine, remoxipride and risperidone on the contractile characteristics of rat skeletal muscle in vitro.
    Mendes LS; Collins SP
    Pharmacol Res; 1997 Dec; 36(6):457-61. PubMed ID: 9446712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
    Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
    Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MDL 73,147EF, a 5-HT3 antagonist, facilitates latent inhibition in the rat.
    Moran PM; Moser PC
    Pharmacol Biochem Behav; 1992 Jul; 42(3):519-22. PubMed ID: 1409784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of remoxipride, an atypical antipsychotic, on cocaine self-administration in the rat using fixed- and progressive-ratio schedules of reinforcement.
    Bourland JA; French ED
    Drug Alcohol Depend; 1995 Dec; 40(2):111-4. PubMed ID: 8745132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning.
    McDonald LM; Moran PM; Vythelingum GN; Joseph MH; Stephenson JD; Gray JA
    Psychopharmacology (Berl); 2003 Sep; 169(3-4):321-31. PubMed ID: 14530903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.
    Weiner I; Lubow RE; Feldon J
    Psychopharmacology (Berl); 1984; 83(2):194-9. PubMed ID: 6431473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response.
    Melo LL; Pereira EC; Pagini CH; Coimbra NC; Brandão ML; Ferrari EA
    Exp Neurol; 2009 Mar; 216(1):16-21. PubMed ID: 19084523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-135,158, a cholecystokinin(B) antagonist, enhances latent inhibition in the rat.
    Gracey DJ; Bell R; King DJ
    Pharmacol Biochem Behav; 2000 Mar; 65(3):459-63. PubMed ID: 10683486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.